Increased risk of intussusception link to rotavirus vaccines

The risk of intussusception (IS) was found to increase by as much as tenfold for RotaTeq (Merck/CSL) and sevenfold for Rotarix (GSK). 

This prompted the TGA to add the new information on the risks to the post-marketing adverse event sections of the product information for both vaccines.